Zobrazeno 1 - 1
of 1
pro vyhledávání: '"N H de la Marre"'
Autor:
A. Maurizot, M Spentchian, P Solvet-Sebire, C. Collet-Gaudillat, P Soury, B Manéglier, B. Livarek, J-P Beressi, J-M Baud, François Guilhot, N H de la Marre, Philippe Rousselot
Publikováno v:
Blood Cancer Journal
Peripheral artery occlusive disease (PAOD) is an emerging adverse event in chronic myelogenous leukemia (CML) patients treated with nilotinib.1, 2, 3, 4 The largest published cohort of CML patients treated with nilotinib comes from the phase III ENES